NetScientific PLC Wanda Announces Significant Data with Partner HRS
May 21 2018 - 2:01AM
RNS Non-Regulatory
TIDMNSCI
NetScientific PLC
21 May 2018
NetScientific plc
("NetScientific" or the "Company" or the "Group")
Significant Reduction in Re-Admissions of High-Risk CHF Patients
Achieved by Wanda and Partner HRS
London, UK - May 21(st) , 2018 - NetScientific plc
("NetScientific", AIM:NSCI), the transatlantic healthcare IP
commercialisation Group, announces that Wanda and Health Resource
Solutions (HRS), Wanda's partner, have successfully achieved a
reduction of 46% in the number of hospitals re-admissions in their
high-risk Congestive Heart Failure patient population. Wanda's
real-time technology continuously assesses patient status and
allows for detection of adverse events up to 7 days in advance of
their occurrence, which has a significant and positive impact on
patients' lives and provides a strong rationale for rolling out the
system to more patients beyond the 576 HRS patients enrolled to
date.
Commenting on the news, Francois R. Martelet, NetScientific's
Chief Executive Officer and Chairman of Wanda, said: "The data are
impressive as patients with congestive heart failure typically have
a very high re-admission rate. This demonstrates the invaluable
potential Wanda's technology has in streamlining care and improving
patient outcomes. We are entering a new digital era of healthcare
in which we firmly believe Wanda can play a pivotal role, and we
are very pleased to see the collaboration with HRS working so
well."
NetScientific holds a 62% stake on a fully diluted basis in
Wanda.
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Ian Postlethwaite,
CFO
Consilium Strategic
Communications Tel: +44 (0)20 3709 5700
Mary-Jane Elliott Jessica netscientific@consilium-comms.com
Hodgson /
Chris Welsh / Laura
Thornton
Stifel Nicolaus Europe Tel: +44 (0) 20 7710 7600
Limited (NOMAD and Broker)
Jonathan Senior / David
Arch / Ben Maddison
About NetScientific
NetScientific is a transatlantic healthcare technology group
with an investment strategy focused on sourcing, funding and
commercialising technologies that significantly improve the health
and well-being of people with chronic diseases. For more
information, please visit the website at www.netscientific.net
Machine Learning, Care Transitions, and Clinical Pathways Reduce
CHF Readmissions by 46%
Chicago, IL - May 21(st) , 2018 - Health Resource Solutions (HRS
Home Health) announces the company achieved another milestone in
their progressive approach to improve care for chronically ill
patients. Over the last two quarters, (Q4 2017 and Q1 2018), HRS
attained a 46% reduction in the readmission rate of their
Congestive Heart Failure patient population. This achievement stems
from the marriage of a dynamic patient management solution driving
care transitions and the clinical pathway protocols at HRS Home
Health.
The CHF patient population, notably one of the most highly
readmitted diagnostic groups nationwide, has been engaged in this
approach during the last six months. The CHF program utilizes the
dynamic patient management system, provided by Wanda, Inc., which
is embedded with machine learning to power the clinical decision
process. Wanda continuously evaluates subtle changes in a patient's
clinical, social, and behavioral health determinants to warn when
an adverse event is likely to transpire - seven days in advance of
the occurrence. Prior to engaging this methodology, this group of
patients had a 34% 30-day readmission rate making them among the
highest readmission rate groups for HRS. By integrating this
technology with services and care pathways, HRS reduced the 30 day
readmission rate to 18.6%
"HRS is excited to drive value and make a measurably positive
impact on the lives of our CHF population. With Wanda, our
clinicians are able to make more informed and timely decisions,
which help us avoid unnecessary adverse events for our patients,"
said Glenn Steigbigel, CEO of HRS. "As providers, we are imbuing
clinical processes with modern technology, which empowers our
clinical teams with real-time actionable information to improve
patient care. This approach benefits patients by providing them
with the support they need while simultaneously reducing the total
cost of care."
As high-risk CHF patients are identified, Wanda facilitates
real-time case management. This is accomplished by empowering
clinicians with virtual intervention features to proactively engage
them in care plan adherence and prevent avoidable adverse
events.
"The incredible results that HRS is achieving are fantastic and
we look forward to continuing our partnership to improve care,"
said Foad Dabiri, CEO Wanda, Inc. "Proactive, real-time data
science is how healthcare will achieve the levels of care and
compliance needed to meet today's expectations."
About Health Resource Solutions
HRS is the largest privately owned high-tech nursing and
rehabilitation home health agency in Chicago, IL. Since 2006, HRS
has integrated data and technologies with home health services to
measure outcomes and increase value for patients leading to
improved outcomes and efficiencies. More information about HRS can
be found at http://www.healthhrs.net
About Wanda, Inc
Wanda is dedicated to advancing the effectiveness and efficiency
of medicine by using machine learning and modern software
applications that empower payers and providers to better manage the
risk and care of patients dramatically lowering the cost of care
and improving outcomes. More information about Wanda can be found
at http://www.yourwanda.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRABRGDURBDBGIG
(END) Dow Jones Newswires
May 21, 2018 02:01 ET (06:01 GMT)
Netscientific (LSE:NSCI)
Historical Stock Chart
From Apr 2024 to May 2024
Netscientific (LSE:NSCI)
Historical Stock Chart
From May 2023 to May 2024